New inhaled asthma therapy tested in early trial
NCT ID NCT05276570
Summary
This study tested a new inhaled drug called ARO-RAGE to see if it is safe and how it behaves in the body. It involved 127 healthy volunteers and people with asthma. The main goal was to check for side effects and measure how the drug moves through the body, with some tests on lung function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Nedlands, Washington, 6009, Australia
-
Research Site 1
Auckland, 1010, New Zealand
-
Research Site 1
Barcelona, 08017, Spain
-
Research Site 1
Bangkok Noi, Bangkok, 10700, Thailand
-
Research Site 2
Auckland, 1051, New Zealand
-
Research Site 2
Krakow, 31-455, Poland
-
Research Site 3
Auckland, 622, New Zealand
-
Research Site 3
Oświęcim, 32-600, Poland
Conditions
Explore the condition pages connected to this study.